Alternative macrophage activation in periprosthetic osteolysis

Autoimmunity

Volumn 41, Issue 3, 2008, Pages 212-217

  Purdue, P Edward ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Alternative macrophage; Periprosthetic osteolysis; Wear debris

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOMATERIAL; CATHEPSIN K; CCL18 CHEMOKINE; CHEMOKINE; CHITOTRIOSIDASE; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN BCL 2; PROTEIN BCL 2A1; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BONE DISEASE; BONE PROSTHESIS; CELL CULTURE; CELL LINEAGE; CELL TYPE; GENE EXPRESSION PROFILING; GENE LOSS; GENE OVEREXPRESSION; HIP OSTEOARTHRITIS; HUMAN; INTESTINE LIPODYSTROPHY; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; NONHUMAN; OSTEOLYSIS; PHAGOCYTOSIS; PHENOTYPE; PROSTHESIS MATERIAL; SARCOIDOSIS; TISSUE ENGINEERING; TOTAL HIP PROSTHESIS;

ANIMALS; HUMANS; JOINT PROSTHESIS; MACROPHAGE ACTIVATION; MACROPHAGES; OSTEOCLASTS; OSTEOLYSIS;

EID: 41449089672     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701694626     Document Type: Article

References (51)

1. Ingham, E. and Fisher, J. (2005) The role of macrophages in osteolysis of total joint replacement. Biomaterials, 26:11, pp. 1271-1286.
2. Purdue, PE, Koulouvaris, P., Potter, HG, Nestor, BJ and Sculco, TP (2007) The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res, 454, pp. 251-261.
3. Dumbleton, JH, Manley, MT and Edidin, AA (2002) A literature review of the association between wear rate and osteolysis in total hip arthroplasty. J Arthroplasty, 17:5, pp. 649-661.
4. Bauer, TW and Schils, J. (1999) The pathology of total joint arthroplasty II. Mechanisms of implant failure. Skeletal Radiol, 28:9, pp. 483-497.
5. Wilkinson, JM, Hamer, AJ, Stockley, I. and Eastell, R. (2005) Polyethylene wear rate and osteolysis: Critical threshold versus continuous dose-response relationship. J Orthop Res, 23:3, pp. 520-525.
6. Willert, HG (1977) Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res, 11:2, pp. 157-164.
7. Schmalzried, TP, Jasty, M. and Harris, WH (1992) Periprosthetic bone loss in total hip arthroplasty polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg Am, 74:6, pp. 849-863.
8. Blaine, TA, Rosier, RN, Puzas, JE, Looney, RJ, Reynolds, PR, Reynolds, SD and O'Keefe, RJ (1996) Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg Am, 78:8, pp. 1181-1192.
9. Nakashima, Y., Sun, DH, Trindade, MC, Maloney, WJ, Goodman, SB, Schurman, DJ and Smith, RL (1999) Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg Am, 81:5, pp. 603-615.
10. Xing, S., Waddell, JE and Boynton, EL (2002) Changes in macrophage morphology and prolonged cell viability following exposure to polyethylene particulate in vitro. Microsc Res Tech, 57:6, pp. 523-529.
11. Rakshit, DS, Ly, K., Sengupta, TK, Nestor, BJ, Sculco, TP, Ivashkiv, LB and Purdue, PE (2006) Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-{gamma} mechanistic insights and implications for periprosthetic osteolysis. J Bone Joint Surg Am, 88:4, pp. 788-799.
12. Schwarz, EM, Lu, AP, Goater, JJ, Benz, EB, Kollias, G., Rosier, RN, Puzas, JE and O'Keefe, RJ (2000) Tumor necrosis factor-alpha/nuclear transcription factor-kappa B signaling in periprosthetic osteolysis. J Orthop Res, 18:3, pp. 472-480.
13. Ingham, E., Green, TR, Stone, MH, Kowalski, R., Watkins, N. and Fisher, J. (2000) Production of TNF-alpha and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials, 21:10, pp. 1005-1013.
14. Maloney, WJ, James, RE and Smith, RL (1996) Human macrophage response to retrieved titanium alloy particles in vitro. Clin Orthop Relat Res, pp. 268-278.
15. Merkel, KD, Erdmann, JM, McHugh, KP, Abu-Amer, Y., Ross, FP and Teitelbaum, SL (1999) Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol, 154:1, pp. 203-210.
16. Wimhurst, JA, Brooks, RA and Rushton, N. (2001) Inflammatory responses of human primary macrophages to particulate bone cements in vitro. J Bone Joint Surg Br, 83:2, pp. 278-282.
17. Wooley, PH, Morren, R., Andary, J., Sud, S., Yang, SY, Mayton, L., Markel, D., Sieving, A. and Nasser, S. (2002) Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials, 23:2, pp. 517-526.
18. Schwarz, EM, Benz, EB, Lu, AP, Goater, JJ, Mollano, AV, Rosier, RN, Puzas, JE and Okeefe, RJ (2000) Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res, 18:6, pp. 849-855.
19. Warme, BA, Epstein, NJ, Trindade, MC, Miyanishi, K., Ma, T., Saket, RR, Regula, D., Goodman, SB and Smith, RL (2004) Proinflammatory mediator expression in a novel murine model of titanium-particle-induced intramedullary inflammation. J Biomed Mater Res B Appl Biomater, 71:2, pp. 360-366.
20. Yang, S., Wu, B., Mayton, L., Evans, CH, Robbins, PD and Wooley, PH (2002) IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model. Inflamm Res, 51:7, pp. 342-350.
21. Yang, SY, Wu, B., Mayton, L., Mukherjee, P., Robbins, PD, Evans, CH and Wooley, PH (2004) Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther, 11:5, pp. 483-491.
22. Childs, LM, Goater, JJ, O'Keefe, RJ and Schwarz, EM (2001) Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res, 16:2, pp. 338-347.
23. Childs, LM, Paschalis, EP, Xing, L., Dougall, WC, Anderson, D., Boskey, AL, Puzas, JE, Rosier, RN, O'Keefe, RJ and Boyce, BF (2002) In vivo RANK signaling blockade using the receptor activator of NF-kappa B: Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res, 17:2, pp. 192-199.
24. Goater, JJ, O'Keefe, RJ, Rosier, RN, Puzas, JE and Schwarz, EM (2002) Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res, 20:2, pp. 169-173.
25. Ulrich-Vinther, M., Carmody, EE, Goater, JJ, Sb, K., O'Keefe, RJ and Schwarz, EM (2002) Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am, 84:8, pp. 1405-1412.
26. Gordon, S. (2003) Alternative activation of macrophages. Nat Rev Immunol, 3:1, pp. 23-35.
27. Mantovani, A., Sica, A. and Locati, M. (2005) Macrophage polarization comes of age. Immunity, 23:4, pp. 344-346.
28. Boot, RG, Verhoek, M., de Fost, M., Hollak, CE, Maas, M., Bleijlevens, B., van Breemen, MJ, van Meurs, M., Boven, LA and Laman, JD (2004) Marked elevation of the chemokine CCL18/PARC in Gaucher disease: A novel surrogate marker for assessing therapeutic intervention. Blood, 103:1, pp. 33-39.
29. Boven, LA, Van Meurs, M., Boot, RG, Mehta, A., Boon, L., Aerts, JM and Laman, JD (2004) Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol, 122:3, pp. 359-369.
30. Hollak, CE, van Weely, S., van Oers, MH and Aerts, JM (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest, 93:3, pp. 1288-1292.
31. Boven, LA, Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, RQ, Boot, RG, Aerts, JM, Amor, S., Nieuwenhuis, EE and Laman, JD (2006) Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain, 129, pp. 517-526.
32. Hamilton, JA (2003) Nondisposable materials, chronic inflammation, and adjuvant action. J Leukoc Biol, 73:6, pp. 702-712.
33. Helming, L. and Gordon, S. (2007) Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. Eur J Immunol, 37:1, pp. 33-42.
34. Lee, CG, Homer, RJ, Zhu, Z., Lanone, S., Wang, X., Koteliansky, V. and Shipley, JM (2001) Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth facto beta (1). J Exp med, 194:6, pp. 809-821.
35. Huaux, F., Liu, T., McGarry, B., Ullenbruch, M. and Phan, SH (2003) Dual roles of IL-4 in lung injury and fibrosis. J Immunol, 170:4, pp. 2083-2092.
36. Hesse, M., Modolell, M., La Flamme, AC, Schito, M., Fuentes, JM, Cheever, AW, Pearce, EJ and Wynn, TA (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: Granulomatous pathology is shaped by the pattern of -arginine metabolism. J Immunol, 167:11, pp. 6533-6544.
37. Hesse, M., Cheever, AW, Jankovic, D. and Wynn, TA (2000) NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am J Pathol, 157:3, pp. 945-955.
38. Chiba, J., Rubash, HE, Kim, KJ and Iwaki, Y. (1994) The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop Relat Res, pp. 304-312.
39. Stea, S., Visentin, M., Granchi, D., Ciapetti, G., Donati, ME, Sudanese, A., Zanotti, C. and Toni, A. (2000) Cytokines and osteolysis around total hip prostheses. Cytokine, 12:10, pp. 1575-1579.
40. Shanbhag, AS, Jacobs, JJ, Black, J., Galante, JO and Glant, TT (1995) Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty. J Arthroplasty, 10:4, pp. 498-506.
41. Koulouvaris, P., Ivashkiv, LB Ly K., Boastrom, MP, Nestor, BJ, Sculco, TP and Purdue, PE (2007) Expression profiling reveals alternative macrophage activation and impaired asteogenesis in periprosthetic osteolysis. J Orthop Res
42. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A. and Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol, 25:12, pp. 677-686.
43. Elias, JA, Homer, RJ, Hamid, Q. and Lee, CG (2005) Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma. J Allergy Clin Immunol, 116:3, pp. 497-500.
44. Bargagli, E., Margollicci, M., Nikiforakis, N., Luddi, A., Perrone, A., Grosso, S. and Rottoli, P. (2004) Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis. Respiration
45. Grosso, S., Margollicci, MA, Bargagli, E., Buccoliero, QR, Perrone, A., Galimberti, D., Morgese, G., Balestri, P. and Rottoli, P. (2004) Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Scand J Clin Lab Invest, 64:1, pp. 57-62.
46. Desnues, B., Lepidi, H., Raoult, D. and Mege, JL (2005) Whipple disease: Intestinal infiltrating cells exhibit a transcriptional pattern of M2/ alternatively activated macrophages. J Infect Dis, 192:9, pp. 1642-1646.
47. Orlofsky, A., Somogyi, RD, Weiss, LM and Prystowsky, MB (1999) The murine antiapoptotic protein A1 is induced in inflammatory macrophages and constitutively expressed in neutrophils. J Immunol, 163:1, pp. 412-419.
48. Humphrey, MB, Daws, MR, Spusta, SC, Niemi, EC, Torchia, JA, Lanier, LL, Seaman, WE and Nakamura, MC (2006) TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J Bone Miner Res, 21:2, pp. 237-245.
49. Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T. and Miyamoto, K. (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med, 202:3, pp. 345-351.
50. Shen, Z., Crotti, TN, McHugh, KP, Matsuzaki, K., Gravallese, EM, Bierbaum, BE and Goldring, SR (2006) The role played by cell-substrate interactions in the pathogenesis of osteoclast-mediated peri-implant osteolysis. Arthritis Res Ther, 8:3, p. R70.
51. Martinez, FO, Gordon, S., Locati, M. and Mantovani, A. (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J Immunol, 177:10, pp. 7303-7311.